Current Report Filing (8-k)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)

June 14, 2017

IRIDEX CORPORATION

(Exact name of registrant as specified in its charter)


Delaware	0-27598	77-0210467
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1212 Terra Bella Avenue

Mountain View, California 94043

(Address of principal executive offices, including zip code)

(650) 940-4700

(Registrant ’ s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.07.Submission of Matters to a Vote of Security Holders.

At the Annual Meeting of Stockholders of IRIDEX Corporation ( “ IRIDEX ” or the “ Company ” ) held on June 14, 2017 (the “ Annual Meeting ” ), the stockholders of IRIDEX re-elected the following individuals to the Board of Directors. Each Director will serve for the ensuing year or until their respective successors are duly elected and qualified.



Nominee	Votes For	Votes Against	Abstentions	Broker Non Votes*
William M. Moore	5,690,433	405,413	1,000	2,884,491
Sanford Fitch	5,583,192	404,945	108,709	2,884,491
Ruediger Naumann-Etienne	5,769,711	214,426	112,709	2,884,491
George Marcellino	5,965,394	18,743	112,709	2,884,491

* Broker non-votes do not affect the outcome of the election.

In addition, the following proposals were voted on and approved at the Annual Meeting.



Proposal	Votes For	Votes Against	Abstentions	Broker Non Votes
Proposal to ratify the appointment of BPM LLP as the independent registered public accountants of the Company for the fiscal year ending December 30, 2017	8,980,777	560	-	-
Proposal to approve, on a non-binding advisory basis, the compensation of the Company ’ s named executive officers as described in the proxy statement	5,675,832	26,378	394,636	2,884,4914
Proposal to approve the amended and restated 2008 Equity Incentive Plan	5,980,009	110,340	6,497	2,884,491

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.